Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
102.50    -2.00 (-1.91%)
Bid:
103.00
Ask:
108.50
Spread: 5.50 (5.34%)
Market Cap: £299.53m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Response to press speculation

29 Jan 2024 07:05

RNS Number : 1932B
Big Technologies PLC
29 January 2024
 

29 January 2024

Big Technologies plc

("Big Technologies" or the "Company")

 

Response to press speculation

 

In response to the article published in The Times on 29 January 2024 (the "Article") regarding the claim as filed with the High Court of Justice England and Wales on 2 August 2023 (and amended and re-filed on 22 November 2023) (the "Claim"), brought by Philippa D'Arcy, Michael and Rhian-Anwen Hamill, Mark Hawtin and Brian Maclaurin, former shareholders of Buddi Limited (representing around 6% of the fully diluted share capital of Buddi Limited in May 2018), the Company reiterates the position set out in the RNS announcement dated 4 August 2023.

 

The Company wishes to make it clear that the particulars of claim as set out in the Article regarding the existence of "undisclosed interests" of Sara Murray in certain of its shareholders are wholly untrue.

 

The Company has taken advice from its lawyers and from King's Counsel and remains confident that the Claim lacks legal and factual merit and intends to defend its position robustly. 

 

The Company will make further announcements regarding the Claim as appropriate.

 

For further information please contact:

 

Big Technologies

via Williams Nicolson

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

 

 

Williams Nicolson (PR Advisers)

Steffan Williams steffan.williams@williamsnicolson.com 

William Barker william.barker@williamsnicolson.com

+44 (0) 7767 345563

+44 (0) 7534 068657

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Jamie Peel / Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

Background

 

As set out within the admission document in July 2021 (the "Admission Document"), a letter of potential claim had been received from Philippa D'Arcy, Michael and Rhian-Anwen Hamill, Mark Hawtin and Brian Maclaurin, former shareholders of Buddi Limited (representing around 6% of the fully diluted share capital of Buddi Limited in May 2018), one of the subsidiaries of the Group, in respect of the operation of a drag mechanism contained in the articles of Buddi Limited that was utilised in connection with the acquisition of Buddi Limited, dating back to May 2018.

 

As was set out on page 138 of the Admission Document, the Company sought legal advice from a number of sources, including solicitors who advised the Company on the operation of the drag mechanism, its solicitors on the placing at IPO and Queen's Counsel. The conclusions were, that having reviewed that advice (which is the subject of legal privilege which is not waived), that the Company is satisfied that the drag mechanism was exercised properly in accordance with its terms and that any claim brought by the former Buddi Limited shareholders would be likely to be defeated.

 

 The Company will make further announcements regarding the Claim as appropriate.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCEAXFNAELLEEA
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.